These data indicate a probiotic–gut microbiota–butyrate–GLP-1 axis that improves metabolic function and protects against high-fat diet-induced obesity and diabetes without using GLP-1 agonists and their side effects [76]. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.